Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Active not recruiting × Locally Advanced Pancreatic Adenocarcinoma × folfirinox × Clear all

Status

Active not recruiting 1

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Pancreatic Neoplasms 5 Resectable Pancreatic Cancer 1 Locally Advanced Pancreatic Adenocarcinoma 1 Gastrointestinal Neoplasms 1 Colonic Neoplasms 1

Interventions

spartalizumab 1 sargramostim 1 folfirinox 1 Surgical Procedures, Operative 1 Specimen Handling 1 Pancreaticoduodenectomy 1 Magnetic Resonance Spectroscopy 1 Leucovorin 1 Laparoscopy 1 Gemcitabine 1 Fluorouracil 1 Colony-Stimulating Factors 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04423731 2024-11-20

Neoadjuvant Chemotherapy in Borderline Resectable and Locally Advanced Pancreatic Cancer (NORPACT-2)

Oslo University Hospital

Active not recruiting

Gastrointestinal

Locally Advanced Pancreatic Adenocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡